imipramine

1
Reactions 514 - 13 Aug 1994 Imipramine Myoclonus: case report Severe myoclonus developed in a 21-year-old woman during imipramine therapy for psychotic bipolar depression. Three or 4 days after her imipramine dose was increased from 150mg to 200mg at bedtime the woman was admitted with suicidal thoughts. She had a relapse of depression and evidence of imipramine adverse effects, despite a modest serum imipramine level. She also had generalised myoclonus both upon action and at rest. Depression persisted, along with delusions of guilt and psychomotor retardation. The woman then developed dystonia after haloperidol was started; this responded to IV diphenhydramine. Benztropine was also started. However, she developed catatonia which, along with most mood symptoms, responded completely to IM lorazepam. Her depressive symptoms later returned. Approximately 9 days after the imipramine dose increase, mild urinary retention developed and myoclonus had increased in severity to 10cm amplitude involuntary movements of all extremities every 2–3 seconds. The woman’s imipramine dosage was decreased to 150 mg at bedtime and lithium was started. Her psychiatric symptoms rapidly improved. Further investigations revealed left-sided schizencephaly and a corresponding history of mild developmental delay. Haloperidol and benztropine were later discontinued. Myoclonus improved, but was still noted 10 days after the imipramine dosage reduction. Several weeks later, imipramine was replaced by desipramine 150mg at bedtime to minimise adverse effects. Within 1 month no definite myoclonus could be seen. Author comment: Consultant neurologists considered that the myoclonus was almost certainly caused by imipramine. ‘Mild myoclonus is reasonably common with various cyclic antidepressants. However, very severe myoclonus induced by an antidepressant is rare.’ Black KJ, et al. Severe imipramine-induced myoclonus in a patient with psychotic bipolar depression, catatonia, and schizencephaly. Annals of Clinical Psychiatry 6: 45-49, Mar 1994 - USA 800285124 1 Reactions 13 Aug 1994 No. 514 0114-9954/10/0514-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: hathu

Post on 18-Mar-2017

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Imipramine

Reactions 514 - 13 Aug 1994

Imipramine

Myoclonus: case reportSevere myoclonus developed in a 21-year-old woman

during imipramine therapy for psychotic bipolar depression.Three or 4 days after her imipramine dose was increased

from 150mg to 200mg at bedtime the woman was admittedwith suicidal thoughts. She had a relapse of depression andevidence of imipramine adverse effects, despite a modestserum imipramine level. She also had generalised myoclonusboth upon action and at rest.

Depression persisted, along with delusions of guilt andpsychomotor retardation. The woman then developeddystonia after haloperidol was started; this responded to IVdiphenhydramine. Benztropine was also started. However,she developed catatonia which, along with most moodsymptoms, responded completely to IM lorazepam. Herdepressive symptoms later returned.

Approximately 9 days after the imipramine dose increase,mild urinary retention developed and myoclonus hadincreased in severity to 10cm amplitude involuntarymovements of all extremities every 2–3 seconds. The woman’simipramine dosage was decreased to 150 mg at bedtime andlithium was started. Her psychiatric symptoms rapidlyimproved. Further investigations revealed left-sidedschizencephaly and a corresponding history of milddevelopmental delay.

Haloperidol and benztropine were later discontinued.Myoclonus improved, but was still noted 10 days after theimipramine dosage reduction. Several weeks later, imipraminewas replaced by desipramine 150mg at bedtime to minimiseadverse effects. Within 1 month no definite myoclonus couldbe seen.

Author comment: Consultant neurologists considered thatthe myoclonus was almost certainly caused by imipramine.‘Mild myoclonus is reasonably common with various cyclicantidepressants. However, very severe myoclonus induced byan antidepressant is rare.’Black KJ, et al. Severe imipramine-induced myoclonus in a patient with psychoticbipolar depression, catatonia, and schizencephaly. Annals of Clinical Psychiatry 6:45-49, Mar 1994 - USA 800285124

1

Reactions 13 Aug 1994 No. 5140114-9954/10/0514-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved